Related Experiment Video
Updated: May 23, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Disability in inflammatory bowel disease
Bincy P Abraham1, Joseph H Sellin
1Section of Gastroenterology and Hepatology, Baylor College of Medicine, 1709 Dryden Street, Suite 800, Houston, TX 77030, USA. bincya@bcm.edu
Disability significantly impacts Inflammatory Bowel Disease (IBD) patients, affecting quality of life and incurring societal costs. A new tool may help assess varied disease effects and guide treatment considerations to reduce these indirect economic burdens.
Area of Science:
- Gastroenterology and Patient-Reported Outcomes
Background:
- Disability in Inflammatory Bowel Disease (IBD) encompasses physical, psychosocial, and employment aspects, impacting patient quality of life.
- IBD-related disability leads to significant indirect societal costs, including workforce loss and increased absenteeism.
Purpose of the Study:
- To highlight the economic impact of disability in IBD patients.
- To introduce a novel tool for assessing disease severity and its varied effects.
- To inform treatment considerations by evaluating potential reductions in indirect costs.
Main Methods:
- Development and validation of a new assessment tool for IBD-related disability.
- Analysis of indirect costs associated with IBD patient disability.
- Evaluation of the tool's utility in establishing disease-specific criteria.
Main Results:
- Disability in IBD patients results in substantial indirect costs to individuals and society.
- The newly developed tool shows promise in characterizing the multifaceted nature of IBD disability.
- The tool can aid in setting criteria for diseases with heterogeneous presentations and severity.
Conclusions:
- Addressing disability in IBD is crucial for improving patient well-being and reducing societal economic burdens.
- The developed tool offers a standardized approach to evaluating IBD-related disability.
- This tool can support informed decision-making regarding treatment strategies aimed at mitigating indirect costs.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations

